Introduction - Aims: In order to search for new sources of bulk drugs, our study group was successfully synthesized new chiral cis-N-heptyl phthalazinone and cis-N-benzyl phthalazinone derivatives with selective phosphodiesterase IV inhibitory activity and stronger anti-inflammatory activity than that of trans derivatives and racemic mixture.